Now in its eighth iteration, the ABPI industry-academic links survey captures vital information from member companies on their interactions with the academic sector, from undergraduate placements to large-scale collaborative projects which bring together industry, academia, charities and the NHS. Interactions are not solely limited to R&D: there is a trend for increasing interactions in areas such as manufacturing, IT and finance.
The 2017 survey has also sought details on the specific interactions that PhD students have with member companies, allowing for a clearer picture of the collaborations between industry and academia at this level. We surveyed 15 companies, seven of them the same as in 2015. Three responses were recorded as ‘nil’. The companies were:
|Alimera Sciences Inc.||GlaxoSmithKline Plc||Pfizer Limited|
|AstraZeneca Plc (inc. MedImmune)||Ipsen Developments Limited||Santen Pharmaceutical Co.|
|Bristol-Myers Squibb Pharmaceuticals Limited||Lilly (Eli Lilly and Company Limited)||Shionogi Inc.|
|Boehringer Ingelheim||Lundbeck Limited||UCB Pharma Limited|
Contract Research Organisations (CROs)
The survey also looked at postdoctoral researchers based in the UK and compared the numbers to other countries. They were divided into two categories.